smProdrugs search icon
Advanced search

Showing results for 'Target/Cell specificity'

Total number of hits: 92
Click on results for more details:
PDIDOTH001

(South)-Methanocarba-Thymidine

Active compound: Thymidine

Indications: Hepatitis b virus (hbv) infection

Target: Thymidine kinase


PDIDB016

Bis(3-PentylOC)PMPA

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDB017

Bis(EthylOC)PMPA

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDB018

Bis(NeopentylOC)PMPA

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDB019

Bis(t-ButylOC)PMPA

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDC003

Canfosfamide

Active compound: Bis[bis(2-chloroethyl)amino]phosphinate

Indications: Colon and breast carcinoma

Target: DNA


PDIDC005

Capecitabine

Active compound: Fluorouracil

Indications: Candida or Cryptococcus neoformans fungal infections

Target: Thymidylate synthase (TS); DNA; RNA


PDIDC010

Cbz–Ser–Ser–Phe–Tyr linked prodrug of 4-aminocylophosphamide

Active compound: Phosphoramide mustard

Indications: Prostate cancer

Target: na


PDIDC036

CHEMBL62755

Active compound: Phenylmethaneselenol

Indications: Kidney cancer

Target: na


PDIDOTH016

4-S-Cysteaminylphenol

Active compound: DTXSID30473723

Indications: Malignant melanoma

Target: Thymidylate synthase and DNA synthesis


PDIDOTH017

5-FP

Active compound: 5-FU

Indications: liver, lung, adrenal, testis, and prostate cancers

Target: Thymidylate synthase


PDIDC110

CTK6D3437

Active compound: FTC

Indications: HIV infection

Target: Reverse Transcriptase


PDIDD003

Dacarbazine

Active compound: 5-Aminoimidazole-4-Carboxamide

Indications: malignant melanoma, Hodgkin's lymphoma, sarcoma, and islet cell carcinoma of the pancreas.

Target: na


PDIDD004

D-alanine

Active compound: Hydrogen peroxide

Indications: Cancer

Target: DNA, Proteins and Lipids


PDIDD007

D-Deprenyl

Active compound: D-amphetamine

Indications: Attention deficit disorder, hyperactivity and narcolepsy

Target: na


PDIDD028

DOX-FCPPs-PyTPE

Active compound: Doxorubicin

Indications: Breast cancer, Bladder cancer and Cervical cancer

Target: DNA topoisomerase 2-alpha, DNA


PDIDD029

Doxifluridine

Active compound: 5-Fluorouracil

Indications: Stomach cancer; Breast cancer

Target: Thymidylate synthase


PDIDD034

DTS-201

Active compound: Doxorubicin

Indications: Breast, colon, prostate, and lung cancers

Target: DNA topoisomerase 2-alpha


PDIDA054

EO9

Active compound: Hydroquinone form of EO9

Indications: Breast and lung cancer

Target: DNA minor grove


PDIDE005

Epirubicin-glucuronide

Active compound: Epirubicin

Indications: Cancer

Target: Topoisomerase II


PDIDE025

Evofosfamide

Active compound: Bromo-isophosphoramide

Indications: Solid tumors

Target: DNA


PDIDF003

Favipiravir

Active compound: Favipiravir riboside triphosphate

Indications: Influenza

Target: viral RNA polymerase


PDIDF004

F-dAdo

Active compound: 2-Fluoroadenine

Indications: Tumors

Target: Purine nucleoside phosphorylase DeoD-type


PDIDF006

Fesoterodine

Active compound: 5-hydroxymethyltolterodine

Indications: Urinary incontinence

Target: M2 and M3 muscarinic receptors


PDIDF008

Flucytosine

Active compound: 5-Fluorouridine 5'-triphosphate

Indications: Candida or Cryptococcus neoformans fungal infections

Target: DNA


PDIDF014

Fmoc-Lys(Ac)-Puromycin

Active compound: Puromycin

Indications: Cancer

Target: 60S ribosomal protein


PDIDF021

Fosnetupitant

Active compound: Netupitant

Indications: Acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy; acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy

Target: Neurokinin-1 (NK-1) receptors


PDIDA013

AC1LAHXM

Active compound: 3'-Fluoro-3'-deoxythymidine

Indications: HIV infection

Target: Reverse Transcriptase


PDIDG002

Gamma-Ghb

Active compound: DTXSID10952728

Indications: Malignant melanoma

Target: Thymidylate synthase and DNA synthesis


PDIDA014

AC1LAHXP

Active compound: 3'-Fluoro-3'-deoxythymidine

Indications: HIV infection

Target: Reverse Transcriptase


PDIDH002

Heroin

Active compound: Morphine

Indications: Pain

Target: μ-opioid receptors


PDIDA015

AC1LAHXS

Active compound: 3'-Fluoro-3'-deoxythymidine

Indications: HIV infection

Target: Reverse Transcriptase


PDIDI009

Isoniazid

Active compound: Isonicotinic Acyl redical

Indications: Tuberculosis (TB)

Target: Enoyl-acyl carrier protein reductase (inha); Catalase-peroxidase


PDIDA016

AC1LAHZV

Active compound: 3'-Fluoro-3'-deoxythymidine

Indications: HIV infection

Target: Reverse Transcriptase


PDIDL001

L-377202

Active compound: Leurubicin

Indications: Prostate cancer

Target: na


PDIDL001

L-377202

Active compound: Doxorubicin

Indications: Prostate cancer

Target: na


PDIDL004

Lansoprazole

Active compound: Sulfenamide form of Lansoprazole

Indications: Erosive reflux oesophagitis, active gastric ulcer, active duodenal ulcer, tuberculosis

Target: (H+,K+)-ATPase


PDIDL005

Latanoprost

Active compound: Latanoprost acid

Indications: Open-angle glaucoma or ocular hypertension; intraocular pressure as a result of angle-closure glaucoma

Target: Prostaglandin F2-alpha receptor


PDIDA018

AC1MHEO9

Active compound: 2-Amino-6-methoxypurine analogue

Indications: Cytomegalo Virus Infection

Target: DNA


PDIDM001

MB07133

Active compound: Ara-CMP

Indications: Myelodysplastic Syndrome; Leukemia; Hepatocellular carcinoma (HCC); liver cancer

Target: AraC triphosphate (araCTP) inhibition of DNA polymerase (By competing with cytidine)


PDIDM002

MB07811

Active compound: MB07344

Indications: Hyperlipidemia

Target: Thyroid hormone receptor beta


PDIDA019

AC1NUIF5

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDM005

Menadione

Active compound: Semiquinone radical

Indications: iver, colon, lung, stomach, and prostateand leukemia

Target: DNA


PDIDM006

MeP-dR

Active compound: 6-Methylpurine

Indications: Tumors

Target: Purine nucleoside phosphorylase DeoD-type


PDIDA020

AC1NUIZT

Active compound: PMPA

Indications: HIV infection

Target: Reverse Transcriptase


PDIDM017

Methyl aminolevulinate

Active compound: Protoporphyrin IX

Indications: Actinic keratosis (R1)

Target: High affinity immunoglobulin gamma Fc receptor I (WL2)


PDIDM019

Mevastatin

Active compound: Hydroxy acid form of Mevastatin

Indications: Bacterial Infections

Target: HMG-CoA reductase


PDIDM024

Mipsagargin

Active compound: Thapsigargin

Indications: Tumor and Cancer

Target: Prostate-specificmembrane antigen (PSMA)


PDIDM025

Mitomycin C

Active compound: Quinone Methide

Indications: Breast, stomach, esophagus, bladder and non-small cell lung cancer

Target: DNA minor grove


PDIDN006

Nepafenac

Active compound: Amfenac

Indications: Pain and inflammation

Target: Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)


PDIDN016

NSC643812

Active compound: Combretastatin

Indications: cancer

Target: Tubulin


PDIDN017

NSC-731657

Active compound: STAVUDINE

Indications: HIV infection

Target: Reverse Transcriptase


PDIDN018

NSC-731658

Active compound: STAVUDINE

Indications: HIV infection

Target: Reverse Transcriptase


PDIDO005

Omeprazole

Active compound: Sulfenamide form of Omeprazole

Indications: Peptic ulcers, zollinger–ellison syndrome, erosive reflux oesophagitis; gastric ulcers

Target: (H+,K+)-ATPase


PDIDO010

Oxycodone

Active compound: Oxymorphone

Indications: Moderate to moderately severe acute or chronic pain.

Target: κ-opioid receptors


PDIDA025

Acetadote

Active compound: L-cysteine

Indications: HIV infection

Target: Glutathione synthetase; Cystine/glutamate transporter


PDIDP005

Pantoprazole

Active compound: Sulfenamide form of Pantoprazole

Indications: Erosive esophagitis associated with gastroesophageal reflux disease (gerd)

Target: (H+,K+)-ATPase


PDIDP006

Paracetamol

Active compound: N-arachidonoylphenolamine

Indications: Pain and fever.

Target: Cyclooxygenase (COX), TRPA1-receptors


PDIDP009

PD1

Active compound: Levofloxacin

Indications: Acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, traveler's diarrhea, tuberculosis, and plague and some types of gastroenteritis

Target: Cell specific


PDIDP010

PD2

Active compound: Levofloxacin

Indications: Urinary tract infection and Pneumonia

Target: Cell specific


PDIDP012

Peptide-doxorubicin prodrug

Active compound: Doxorubicin

Indications: Tumor

Target: na


PDIDP021

PR-104

Active compound: PR-104M

Indications: Solid tumors, Lung cancer, And leukemia

Target: DNA


PDIDP022

PR-104A

Active compound: PR-104M

Indications: Solid tumors, Lung cancer, And leukemia

Target: DNA


PDIDP038

Progabide

Active compound: SL-75102

Indications: Epilepsy

Target: GABAA, GABAB, and GABAA-ρ receptors


PDIDA029

Adefovir Dipivoxil

Active compound: Adefovir

Indications: Hepatitis b virus

Target: Reverse transcriptase


PDIDR004

Rabeprazole

Active compound: Sulfenamide form of Rabeprazole

Indications: Erosive esophagitis associated with gastroesophageal reflux disease (gerd)

Target: na


PDIDR010

Rescula

Active compound: Unoprostone

Indications: Occular Hypertension

Target: na


PDIDR016

Ro-48-3656

Active compound: Ro 44-3888

Indications: Acute coronary syndrome

Target: Fibrinogen receptor; GP IIb-IIIa receptor


PDIDR019

Ropidoxuridine

Active compound: Idoxuridine

Indications: Radiosensitizer

Target: Thymidylate synthase


PDIDS003

SB 204990

Active compound: SB 201076

Indications: Hypolipidaemia

Target: ATP citrate (pro-S)-lyase


PDIDA033

Alacepril

Active compound: Captopril

Indications: Hypertension and congestive heart failure

Target: Angiotensin-converting-enzyme inhibitor


PDIDS022

SCHEMBL4047434

Active compound: Eniluracil

Indications: liver, lung, adrenal, testis, and prostate cancers

Target: Mechanism-based inhibitor of dihy-dropyrimidine dehydrogenase (DPD)


PDIDS026

SCHEMBL6711678

Active compound: 6-Mercaptopurine

Indications: Colon and breast carcinoma

Target: DNA


PDIDS036

Sibrafiban

Active compound: Ro 44-3888

Indications: Acute coronary syndrome

Target: Fibrinogen receptor; GP IIb-IIIa receptor


PDIDS040

SNX-5422

Active compound: SNX-2112

Indications: Breast, lung, and ovarian cancer

Target: Heat shock protein HSP 90


PDIDA037

Aldoxorubicin

Active compound: Doxorubicin

Indications: Solid tumors

Target: DNA topoisomerase 2-alpha


PDIDT012

Tegafur

Active compound: 5-Fluorouracil

Indications: Candida or Cryptococcus neoformans fungal infections

Target: Thymidylate Synthase (TS)


PDIDT017

Temozolomide

Active compound: 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC)

Indications: Brain cancers, astrocytoma, glioblastoma multiforme

Target: DNA (alkylating agent)


PDIDT022

Testifenon

Active compound: Dihydrotestosterone

Indications: Tumor and Cancer

Target: Androgen receptor


PDIDT029

Thymectacin

Active compound: Brivudine monophosphate

Indications: Tumours

Target: Thymidylate synthase (ts)


PDIDT029

Thymectacin

Active compound: Brivudine

Indications: Colorectal cancer

Target: Thymidylate synthase


PDIDT033

Tirapazamine

Active compound: Benzotriazinyl radicals

Indications: Breast and lung cancer

Target: DNA minor grove


PDIDT035

Tolterodine

Active compound: 5-Hydroxymethyltolterodine (5-HMT)

Indications: Urinary incontinence

Target: M2 and M3 muscarinic receptors


PDIDT038

Travoprost

Active compound: Travoprost free acid

Indications: Glaucoma or ocular hypertension

Target: FP prostanoid receptor


PDIDV010

VX-765

Active compound: VRT-043198

Indications: Inflamation, Psoriasis and psoriatic disorders

Target: ICE/caspase-1 sub-family caspases


PDIDZ001

Zidovudine prodrug

Active compound: AZT triphosphate

Indications: HIV infection

Target: DNA polymerase


PDIDA046

Amifostine

Active compound: WR-1065

Indications: Cytoprotective adjuvant used in cancer

Target: na


PDIDA054

Aniline mustard glucuronide

Active compound: Aniline mustard

Indications: Colon cancer

Target: Beta-glucuronidase-positive cells


PDIDA055

Apaziquone

Active compound: Semi-quinone radical form of EO9

Indications: Breast and lung cancer

Target: DNA minor grove


PDIDOTH008

2,4-Dopa

Active compound: 6-Hydroxydopa

Indications: Malignant melanoma

Target: DNA, RNA, and protein synthesis


PDIDB002

Baloxavir marboxil

Active compound: Baloxavir

Indications: Influenza

Target: Polymerase acidic (PA) protein found in influenza virus


PDIDB005

Banoxantrone

Active compound: AQ4

Indications: Tumor

Target: Topoisomerase II